| 摘要 |
<p>The present invention relates to a taxol-based liposome composition for treatment of cancer, which is substantially consist of following material by weight: taxol 2-5 parts, phosphatide 20-200 parts, cholesterol 2-20 parts, amino acids 0.3-4 parts, lyophilized excipient 10-75 parts. The products according to the present invention do not contain polyoxyethylated castor oil, and substituted the toxic and expensive adjutant with nontoxic media and easily obtained adjutant, can execute in industry, they have advantages of low toxicity, good tolerance for patient and better stability or like.</p> |
